Maspin, VEGF and p53 expression in small biopsies of primary advanced lung cancer and relationship with clinicopathologic parameters

Pathology and Oncology Research

Volumn 16, Issue 4, 2010, Pages 553-561

  Bircan, Ahmet ^a   Bircan, Sema ^a   Kapucuoglu, Nilgun ^a   Songur, Necla ^a   Ozturk, Onder ^a   Akkaya, Ahmet ^a  

^a SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Biopsy; Immunohistochemistry; Lung cancer; Maspin; p53; VEGF

Indexed keywords

MASPIN; PROTEIN P53; VASCULOTROPIN;

ADULT; ADVANCED CANCER; ARTICLE; CANCER STAGING; CONTROLLED STUDY; CYTOPLASM; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG BIOPSY; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIMARY TUMOR; PROGNOSIS; PROTEIN EXPRESSION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SERPINS; SMALL CELL LUNG CARCINOMA; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 78149410165     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12253-010-9259-5     Document Type: Article

References (40)

1. Z Zou A Anisowicz MJ Hendrix, et al. 1994 Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells Science 263 526 529 1:CAS:528:DyaK2cXhsFOntb4%3D 10.1126/science.8290962 8290962
2. EI Chen JR Yates 2006 Maspin and tumor metastasis IUBMB Life 58 25 29 1:CAS:528:DC%2BD28XisVaqtbw%3D 10.1080/15216540500531721 16540429
3. CM Bailey Z Khalkhali-Ellis EA Seftor, et al. 2006 Biological functions of Maspin J Cell Physiol 209 617 624 1:CAS:528:DC%2BD28XhtFOktL3M 10.1002/jcp.20782 17001697 (Pubitemid 44665678)
4. J Lockett S Yin X Li, et al. 2006 Tumor suppressive maspin and epithelial homeostasis J Cell Biochem 97 651 660 1:CAS:528:DC%2BD28Xis1Crs70%3D 10.1002/jcb.20721 16329135
5. M Zhang O Volpert YH Shi, et al. 2000 Maspin is an angiogenesis inhibitor Nat Med 6 196 199 10.1038/72303 10655109 (Pubitemid 30082365)
6. M Nakagawa H Katakura M Adachi, et al. 2006 Maspin expression and its clinical significance in non-small cell lung cancer Ann Surg Oncol 13 1517 1523 10.1245/s10434-006-9030-z 17009165 (Pubitemid 44749664)
7. M Woenckhaus L Bubendorf P Dalquen, et al. 2007 Nuclear and cytoplasmic maspin expression in primary non-small cell lung cancer J Clin Pathol 60 483 486 1:CAS:528:DC%2BD2sXnt1Gkuro%3D 10.1136/jcp.2005.033407 16698957 (Pubitemid 46867155)
8. I Takanami T Abiko S Koizumi 2008 Expression of maspin in non-small-cell lung cancer: correlation with clinical features Clin Lung Cancer 9 361 366 10.3816/CLC.2008.n.052 19073519
9. H Katakura K Takenaka M Nakagawa, et al. 2006 Maspin gene expression is a significant prognostic factor in resected non-small cell lung cancer (NSCLC). Maspin in NSCLC Lung Cancer 51 323 328 10.1016/j.lungcan.2005.10.017 16406136 (Pubitemid 43265815)
10. K Hirai K Koizumi S Haraguchi, et al. 2005 Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer Ann Thorac Surg 79 248 253 10.1016/j.athoracsur.2004.06.118 15620951 (Pubitemid 40037479)
11. HC Zheng H Saito S Masuda, et al. 2008 Cytoplasmic and nuclear maspin expression in lung carcinomas: an immunohistochemical study using tissue microarrays App Immunohistochem Mol Morphol 16 459 465 1:CAS:528: DC%2BD1cXhtFCrtbfE 10.1097/PAI.0b013e3181640bb1
12. M Nakashima N Ohike K Nagasaki, et al. 2004 Prognostic significance of the maspin tumor suppressor gene in pulmonary adenocarcinoma J Cancer Res Clin Oncol 130 475 479 1:CAS:528:DC%2BD2cXls1CjsLc%3D 10.1007/s00432-004-0571-x 15197584 (Pubitemid 39119291)
13. F Lonardo X Li F Siddiq, et al. 2006 Maspin nuclear localization is linked to favorable morphological features in pulmonary adenocarcinoma Lung Cancer 51 31 39 10.1016/j.lungcan.2005.07.011 16159682 (Pubitemid 43088622)
14. A Frey AO Soubani AK Adam, et al. 2009 Nuclear, compared with combined nuclear and cytoplasmic expression of maspin, is linked in lung adenocarcinoma to reduced VEGF-A levels and in Stage I, improved survival Histopathology 54 590 597 10.1111/j.1365-2559.2009.03260.x 19309490
15. A Yilmaz D Ernam E Unsal, et al. 2007 Vascular endothelial growth factor immunostaining correlates with postoperative relapse and survival in non-small cell lung cancer Arch Med Res 38 764 768 1:CAS:528:DC%2BD2sXhtVWmtr%2FJ 10.1016/j.arcmed.2007.04.005 17845896 (Pubitemid 47368722)
16. RM Bremnes C Camps R Sirera 2006 Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood Lung Cancer 51 143 158 10.1016/j.lungcan.2005.09.005 16360975 (Pubitemid 43144358)
17. L Boldrini S Gisfredi S Ursino, et al. 2005 Interleukin-8 in non-small cell lung carcinoma: relation with angiogenic pattern and p53 alterations Lung Cancer 50 309 317 10.1016/j.lungcan.2005.07.002 16125276
18. CQ Zhu W Shih CH Ling, et al. 2006 Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation J Clin Pathol 59 790 800 1:CAS:528: DC%2BD28Xpt1yhtb0%3D 10.1136/jcp.2005.031351 16873561 (Pubitemid 44211740)
19. M Hollstein D Sidransky B Volgestein, et al. 1991 p53 mutation in human cancers Science 253 49 53 1:CAS:528:DyaK3MXks1Gmurg%3D 10.1126/science.1905840 1905840
20. Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC (2004) World Health Organization classification of tumours. Pathology and genetics of tumours of the lung, pleura, thymus and heart. IARC Press, Lyon
21. V Ludovini V Gregorc L Pistola, et al. 2004 Vascular endothelial growth factor, p53, Rb, Bcl-2 expression and response to chemotherapy in advanced non-small cell lung cancer Lung Cancer 46 77 85 10.1016/j.lungcan.2004.03.018 15364135 (Pubitemid 39201386)
22. SJ Freemantle E Dmitrovsky 2002 Clinical link between p53 and angiogenesis in lung cancer J Clin Oncol 20 883 884 1:CAS:528: DC%2BD38XitFOqtLc%3D 11844804
23. A Yuan CJ Yu KT Luh, et al. 2002 Aberrant p53 expression correlates with expression of vascular endothelial growth factor mRNA and interleukin-8 mRNA and neoangiogenesis in non-small-cell lung cancer J Clin Oncol 20 900 910 1:CAS:528:DC%2BD38XitFOqtbw%3D 10.1200/JCO.20.4.900 11844810 (Pubitemid 34141831)
24. D Mukhopadhyay L Tsiokas VP Sukhatme 1995 Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression Cancer Res 57 6161 6165
25. Z Zou C Gao AK Nagaich, et al. 2000 p53 regulates the expression of the tumor suppressor gene maspin J Biol Chem 275 6051 6054 1:CAS:528: DC%2BD3cXhslWrsrg%3D 10.1074/jbc.275.9.6051 10692390 (Pubitemid 30129884)
26. MM Oken RH Creech DC Tormey, et al. 1982 Toxicity and response criteria of the Eastern Cooperative Oncology Group Am J Clin Oncol 5 649 655 1:STN:280:DyaL3s7kvFOgsw%3D%3D 10.1097/00000421-198212000-00014 7165009
27. CF Mountain 1997 Revisions in the international system for staging lung cancer Chest 111 1710 1717 1:STN:280:DyaK2szjtVOguw%3D%3D 10.1378/chest.111.6. 1710 9187198
28. RA Stahel R Ginsberg K Havemann, et al. 1989 Staging and prognostic factors in small cell lung cancer: a consensus report Lung Cancer 5 119 126 10.1016/0169-5002(89)90156-6
29. SL Smith SG Watson D Ratschiller, et al. 2003 Maspin- the most commonly expressed gene of the 18q21.3 serpin cluster in lung cancer- is strongly expressed in preneoplastic bronchial lesions Oncogene 22 8677 8687 1:CAS:528:DC%2BD3sXptlGgurg%3D 10.1038/sj.onc.1207127 14647462 (Pubitemid 38010491)
30. E Steels M Paesmans T Berghamans, et al. 2001 Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis Eur Respir J 18 705 719 1:CAS:528:DC%2BD3MXpt1Kisrw%3D 10.1183/09031936.01.00062201 11716177 (Pubitemid 33040631)
31. J Laudanski W Niklinska T Burzykowski, et al. 2001 Prognostic significance of p53 and bcl-2 abnormalities in operable nonsmall cell lung cancer Eur Respir J 17 660 666 1:STN:280:DC%2BD38%2Fht1amug%3D%3D 10.1183/09031936.01.17406600 11401061 (Pubitemid 32492554)
32. MS Tsao S Aviel-Ronen K Ding, et al. 2007 Prognostic and predictive importance of p53 and RAS for adjuvant chemotherapy in non small-cell lung cancer J Clin Oncol 25 5240 5247 10.1200/JCO.2007.12.6953 18024870 (Pubitemid 350232256)
33. KJ O'Byrne MI Koukourakis A Giatromanolaki, et al. 2000 Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer Br J Cancer 82 1427 1432 10780522 (Pubitemid 30175909)
34. G Fontanini L Boldrini S Vignati, et al. 1998 Bcl-2 and p53 regulate vascular endothelial growth factor (VEGF)-mediated angiogenesis in non-small cell lung carcinoma Eur J Cancer 34 718 723 1:STN:280:DyaK1cznvV2jsA%3D%3D 10.1016/S0959-8049(97)10145-9 9713280 (Pubitemid 28218950)
35. J Yoo JH Yung MA Lee, et al. 2007 Immunohistochemical analysis of non-small cell lung cancer: correlation with clinical parameters and prognosis J Korean Med Sci 22 318 325 10.3346/jkms.2007.22.2.318 17449943
36. H Ito F Oshita Y Kameda, et al. 2002 Expression of vascular endothelial growth factor and basic fibroblast growth factor in small adenocarcinomas Oncol Rep 9 119 123 1:CAS:528:DC%2BD38XmtVSiug%3D%3D 11748468
37. T Seto M Higashiyama H Funai, et al. 2006 Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small- cell lung cancer Lung Cancer 53 91 96 10.1016/j.lungcan.2006.02.009 16697074 (Pubitemid 43831360)
38. M Liao H Wang Z Lin, et al. 2001 Vascular endothelial growth factor and other biological predictors related to the postoperative survival rate on non-small cell lung cancer Lung Cancer 33 125 132 1:STN:280: DC%2BD3MrgtF2gug%3D%3D 10.1016/S0169-5002(01)00195-7 11551407 (Pubitemid 32707893)
39. T Nakashima CL Huang D Liu, et al. 2004 Expression of vascular endothelial growth factor-A and vascular endothelial growth factor-C as prognostic factors for non small cell lung cancer Med Sci Monit 10 BR157 BR165 1:CAS:528:DC%2BD2cXmslCgsLg%3D 15173661
40. W Niklinska T Burzykowski L Chyczewski J Niklinski 2001 Expression of vascular endothelial growth factor (VEGF) in non-small cell lung cancer (NSCLC): association with p53 gene mutation and prognosis Lung Cancer 34 S59 S64 10.1016/S0169-5002(01)00346-4 11720743